Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Australia returns to "war footing" amid COVID-19 vaccine turmoil

Published 14/04/2021, 10:26 am
Updated 14/04/2021, 10:30 am

By Renju Jose

SYDNEY, April 14 (Reuters) - Australia's national cabinet will begin meeting twice a week from Monday, marking a return to a "war footing" in the country's battle against the coronavirus pandemic amid turmoil in its national vaccination programme.

Prime Minister Scott Morrison said on Wednesday the return to more frequent meetings of the group of federal and state government leaders was necessary to address "serious challenges" caused by patchy international vaccine supplies and changing medical advice.

"This is a complex task and there are problems with the programme that we need to solve to ensure more Australians can be vaccinated safely and more quickly," Morrison said in a statement.

Australia has fared much better than many other developed countries during the pandemic, with just over 29,400 COVID-19 cases and 910 deaths.

No new cases have been reported on most days this year and officials have swiftly contained small outbreaks, but the country's vaccination programme has hit major roadblocks.

Morrison earlier this week abandoned a target to provide at least one vaccine dose to the country's near 26 million population by year-end after restricting the rollout of its favoured AstraZeneca (NASDAQ:AZN) AZN.L vaccine.

Findings by Europe's drug regulator of rare cases of blood clots among some adult recipients of the AstraZeneca vaccine were a major blow for Australia as the country had based its immunisation drive largely on that inoculation, with plans to manufacture 50 million doses locally. officials overhauled the programme in response, doubling an earlier Pfizer (NYSE:PFE) PFE.N order to 40 million shots and restricting AstraZeneca doses to people under 50.

The rollout has also been affected by export curbs imposed by the European Union on vaccines as the bloc seeks to shore up its own supplies.

Trade Minister Dan Tehan is due to travel to Europe this week to seek the release of about 3 million doses of previously promised AstraZeneca vaccines.

Morrison created a national cabinet of federal, state and territory leaders early last year to coordinate measures to combat the pandemic. There has been sniping in recent weeks between different levels of government about who is responsible for delays in the vaccine rollout.

The return to twice weekly meetings, the same frequency as at the peak of the crisis last year, would continue for the "foreseeable future", Morrison said, without providing detail on any potential steps to be taken.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.